Evidence map›Paper›PMID 33917979›Full record

ArticlePharmaceutics2021

Structural Analysis of the Simultaneous Activation and Inhibition of γ-Secretase Activity in the Development of Drugs for Alzheimer's Disease.

Željko M Svedružić, Katarina Vrbnjak, Manuel Martinović, Vedran Miletić

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Screening of [ACS pharmacology & translational science · 2024
    Article
  5. ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9.International journal of molecular sciences · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. γ-secretase targeting in Alzheimer's disease.Journal of Alzheimer's disease reports
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Željko M SvedružićDepartment of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0002-0736-6182
Katarina VrbnjakDepartment of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.
Manuel MartinovićDepartment of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.
Vedran MiletićDepartment of Informatics, University of Rijeka, 51000 Rijeka, Croatia.
University of Rijeka · HR

Funding

European Regional Development Fund RC.2.2.06-0001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimeravagacestatdrug-designfamilial Alzheimer’s diseasemodulation of enzyme activitymolecular dynamicssemagacestat

Identifiers

PMID33917979
PMCPMC8068388
OpenAlexW3146522233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.